Home › Blend Therapeutics Appoints Drew Fromkin as President and Chief Executive Officer
 

Keywords :   


Blend Therapeutics Appoints Drew Fromkin as President and Chief Executive Officer

2015-04-13 16:44:27| Biotech - Topix.net

Blend Therapeutics, Inc. , a biopharmaceutical company discovering and developing two distinct classes of targeted anti-cancer medicines to advance the treatment of patients with solid tumor cancers, announced today the appointment of Drew Fromkin as President and Chief Executive Officer and a member of the company's Board of Directors. Mr. Fromkin previously served as President and Chief Executive Officer of Clinical Data, Inc., until its acquisition by Forest Laboratories.

Tags: executive president chief officer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Tropical Storm Beryl Potential Storm Surge Flooding Map
05.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
05.07Tropical Storm Beryl Storm Surge Watch/Warning Map
05.07Tropical Storm Beryl Storm Surge Watch/Warning Map
05.07Tropical Storm Beryl Graphics
05.07Tropical Storm Beryl Graphics
05.07Tropical Storm Beryl Forecast Discussion Number 29
05.07Tropical Storm Beryl Wind Speed Probabilities Number 29
More »